NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Akura Medical

Akura Medical

Private
Los Gatos, CaliforniaHealthcare & Life Scienceshttps://www.akuramedical.com/

Last Round

Series C

Dec 1, 2025

Est. Valuation

$215M

Total Funding Raised

$115M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Akura Medical is a medical technology company that develops mechanical thrombectomy systems and integrated imaging software to treat venous thromboembolism.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

mechanical thrombectomypulmonary embolismvenous thromboembolismclot removalminimally invasive surgerythrombectomy deviceVTEPEinterventional cardiologyvascular surgerymedical devicethrombectomy systemmedtechprocedural planningthrombus quantification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Akura Medical Comps

Public and private peers based on sector, stage, and business model.

Akura Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Akura Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CDec 1, 2025
Series BOct 3, 2023
Series A ExtensionJan 10, 2022

Akura Medical Investors

Notable investors and investment history

Akura Medical investors
InvestorRounds
ShifamedSeries B, Series A Extension, Seed
Cormorant Asset ManagementSeries C, Series B, Series A Extension
Unorthodox VenturesSeries B, Series C
The Capital PartnershipSeries A Extension, Series C, Series B
PA MedTech VC FundSeries B, Series A Extension, Series C
Lilly Asia VenturesSeries B, Series C
Lilly Asia VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2025

    Raised $53M led by Qatar Investment Authority.

Akura Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Akura Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Akura Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Gatos, California
Employee Range34
Year Founded2019
Last FundingDec 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.